Theratechnologies Inc. (TH.TO)
CAD 2.18
(0.46%)
CAD 2.18
(0.46%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 98.63 Million USD | -14.84% |
| 2022 | 115.83 Million USD | 14.17% |
| 2021 | 101.45 Million USD | 4.68% |
| 2020 | 96.91 Million USD | 4.53% |
| 2019 | 92.72 Million USD | 21.68% |
| 2018 | 76.19 Million USD | 195.6% |
| 2017 | 25.77 Million USD | 32.78% |
| 2016 | 19.41 Million USD | -13.64% |
| 2015 | 22.48 Million USD | 3.89% |
| 2014 | 21.63 Million USD | 263.74% |
| 2013 | 5.94 Million USD | -56.74% |
| 2012 | 13.75 Million USD | -14.08% |
| 2011 | 16 Million USD | -14.08% |
| 2010 | 18.63 Million USD | -25.46% |
| 2009 | 24.99 Million USD | 331.28% |
| 2008 | 5.79 Million USD | -32.67% |
| 2007 | 8.6 Million USD | 51.34% |
| 2006 | 5.68 Million USD | 43.21% |
| 2005 | 3.97 Million USD | -5.6% |
| 2004 | 4.2 Million USD | -49.87% |
| 2003 | 8.39 Million USD | -18.27% |
| 2002 | 10.26 Million USD | -47.14% |
| 2001 | 19.42 Million USD | 18.05% |
| 2000 | 16.45 Million USD | 1001.62% |
| 1999 | 1.49 Million USD | -0.23% |
| 1998 | 1.49 Million USD | 1.47% |
| 1997 | 1.47 Million USD | -66.86% |
| 1996 | 4.45 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q3 | 89.38 Million USD | -4.32% |
| 2024 Q1 | 96.69 Million USD | -1.97% |
| 2024 Q2 | 93.42 Million USD | -3.38% |
| 2023 Q1 | 111.55 Million USD | -3.7% |
| 2023 FY | 98.63 Million USD | -14.84% |
| 2023 Q4 | 98.63 Million USD | 0.25% |
| 2023 Q3 | 98.39 Million USD | -10.77% |
| 2023 Q2 | 110.26 Million USD | -1.15% |
| 2022 Q4 | 115.83 Million USD | 1.68% |
| 2022 FY | 115.83 Million USD | 14.17% |
| 2022 Q3 | 113.91 Million USD | 6.46% |
| 2022 Q2 | 107 Million USD | 8.62% |
| 2022 Q1 | 98.51 Million USD | -2.9% |
| 2021 Q3 | 100.13 Million USD | 1.8% |
| 2021 Q2 | 98.36 Million USD | 3.89% |
| 2021 FY | 101.45 Million USD | 4.68% |
| 2021 Q4 | 101.45 Million USD | 1.32% |
| 2021 Q1 | 94.67 Million USD | -2.31% |
| 2020 Q1 | 90 Million USD | -2.93% |
| 2020 Q4 | 96.91 Million USD | 4.24% |
| 2020 Q3 | 92.97 Million USD | -3.48% |
| 2020 Q2 | 96.33 Million USD | 7.03% |
| 2020 FY | 96.91 Million USD | 4.53% |
| 2019 Q1 | 82.36 Million USD | 8.09% |
| 2019 FY | 92.72 Million USD | 21.68% |
| 2019 Q2 | 79.27 Million USD | -3.75% |
| 2019 Q4 | 92.72 Million USD | 18.8% |
| 2019 Q3 | 78.04 Million USD | -1.55% |
| 2018 Q4 | 76.19 Million USD | 4.63% |
| 2018 FY | 76.19 Million USD | 195.6% |
| 2018 Q3 | 72.82 Million USD | 202.88% |
| 2018 Q2 | 24.04 Million USD | -3.47% |
| 2018 Q1 | 24.9 Million USD | -3.37% |
| 2017 FY | 25.77 Million USD | 32.78% |
| 2017 Q4 | 25.77 Million USD | 20.39% |
| 2017 Q3 | 21.41 Million USD | -5.92% |
| 2017 Q1 | 22.21 Million USD | 14.45% |
| 2017 Q2 | 22.75 Million USD | 2.42% |
| 2016 Q3 | 18.98 Million USD | -9.83% |
| 2016 FY | 19.41 Million USD | -13.64% |
| 2016 Q1 | 22.68 Million USD | 0.89% |
| 2016 Q2 | 21.05 Million USD | -7.18% |
| 2016 Q4 | 19.41 Million USD | 2.28% |
| 2015 FY | 22.48 Million USD | 3.89% |
| 2015 Q3 | 24.67 Million USD | 3.11% |
| 2015 Q4 | 22.48 Million USD | -8.91% |
| 2015 Q2 | 23.93 Million USD | 4.09% |
| 2015 Q1 | 22.99 Million CAD | 6.27% |
| 2014 FY | 21.63 Million USD | 263.74% |
| 2014 Q4 | 21.63 Million USD | 10.22% |
| 2014 Q2 | 19.64 Million USD | 250.92% |
| 2014 Q1 | 5.59 Million USD | -5.9% |
| 2014 Q3 | 19.63 Million USD | -0.06% |
| 2013 Q4 | 5.94 Million USD | 4.28% |
| 2013 FY | 5.94 Million USD | -56.74% |
| 2013 Q3 | 5.7 Million USD | -10.97% |
| 2013 Q2 | 6.4 Million USD | -25.66% |
| 2013 Q1 | 8.61 Million USD | -37.33% |
| 2012 Q3 | 14.13 Million USD | -3.29% |
| 2012 FY | 13.75 Million USD | -14.08% |
| 2012 Q2 | 14.61 Million USD | -12.81% |
| 2012 Q1 | 16.75 Million USD | 4.68% |
| 2012 Q4 | 13.75 Million USD | -2.67% |
| 2011 Q4 | 16 Million USD | -15.6% |
| 2011 FY | 16 Million USD | -14.08% |
| 2011 Q3 | 18.96 Million USD | -5.83% |
| 2011 Q2 | 20.14 Million USD | 8.46% |
| 2011 Q1 | 18.56 Million USD | -0.34% |
| 2010 Q4 | 18.63 Million USD | 1.86% |
| 2010 Q1 | 21.79 Million USD | -12.81% |
| 2010 FY | 18.63 Million USD | -25.46% |
| 2010 Q2 | 22.94 Million USD | 5.27% |
| 2010 Q3 | 18.29 Million USD | -20.27% |
| 2009 Q2 | 27.01 Million USD | 4.81% |
| 2009 Q3 | 24.49 Million USD | -9.33% |
| 2009 Q4 | 24.99 Million USD | 2.03% |
| 2009 FY | 24.99 Million USD | 331.28% |
| 2009 Q1 | 25.77 Million USD | 344.75% |
| 2008 Q1 | 9.05 Million USD | 5.23% |
| 2008 FY | 5.79 Million USD | -32.67% |
| 2008 Q4 | 5.79 Million USD | -43.83% |
| 2008 Q3 | 10.31 Million USD | -10.62% |
| 2008 Q2 | 11.54 Million USD | 27.44% |
| 2007 Q3 | 9 Million USD | 51.56% |
| 2007 Q4 | 8.6 Million USD | -4.35% |
| 2007 FY | 8.6 Million USD | 51.34% |
| 2007 Q1 | 5.73 Million USD | 0.86% |
| 2007 Q2 | 5.93 Million USD | 3.51% |
| 2006 Q2 | 4.16 Million USD | -8.05% |
| 2006 Q1 | 4.52 Million USD | 13.97% |
| 2006 FY | 5.68 Million USD | 43.21% |
| 2006 Q3 | 5.1 Million USD | 22.54% |
| 2006 Q4 | 5.68 Million USD | 11.52% |
| 2005 FY | 3.97 Million USD | -5.6% |
| 2005 Q2 | 3.28 Million USD | -27.86% |
| 2005 Q1 | 4.55 Million USD | 8.17% |
| 2005 Q3 | 3.09 Million USD | -5.84% |
| 2005 Q4 | 3.97 Million USD | 28.48% |
| 2004 Q4 | 4.2 Million USD | 72.87% |
| 2004 Q3 | 2.43 Million USD | -41.44% |
| 2004 Q2 | 4.15 Million USD | -20.96% |
| 2004 Q1 | 5.25 Million USD | -37.34% |
| 2004 FY | 4.2 Million USD | -49.87% |
| 2003 Q1 | 9.52 Million USD | -7.21% |
| 2003 FY | 8.39 Million USD | -18.27% |
| 2003 Q4 | 8.39 Million USD | -12.55% |
| 2003 Q3 | 9.59 Million USD | 1.55% |
| 2003 Q2 | 9.45 Million USD | -0.82% |
| 2002 Q1 | 16.59 Million CAD | -14.57% |
| 2002 Q4 | 10.26 Million USD | 8.55% |
| 2002 Q3 | 9.46 Million CAD | 0.83% |
| 2002 Q2 | 9.38 Million CAD | -43.47% |
| 2002 FY | 10.26 Million USD | -47.14% |
| 2001 Q3 | 18.02 Million CAD | 31.49% |
| 2001 Q1 | 15.86 Million CAD | -3.62% |
| 2001 FY | 19.42 Million USD | 18.05% |
| 2001 Q2 | 13.71 Million CAD | -13.56% |
| 2001 Q4 | 19.42 Million CAD | 7.76% |
| 2000 Q1 | 1.86 Million CAD | 24.54% |
| 2000 Q3 | 9.16 Million USD | -3.95% |
| 2000 FY | 16.45 Million USD | 1001.62% |
| 2000 Q4 | 16.45 Million CAD | 79.54% |
| 2000 Q2 | 9.54 Million USD | 412.91% |
| 1999 Q1 | 1.39 Million USD | -7.03% |
| 1999 Q2 | 1.35 Million USD | -2.57% |
| 1999 FY | 1.49 Million USD | -0.23% |
| 1999 Q4 | 1.49 Million USD | 17.52% |
| 1999 Q3 | 1.27 Million USD | -6.28% |
| 1998 Q3 | 1.51 Million USD | -14.92% |
| 1998 Q2 | 1.78 Million USD | 20.97% |
| 1998 Q1 | 1.47 Million USD | -0.01% |
| 1998 Q4 | 1.49 Million USD | -1.4% |
| 1998 FY | 1.49 Million USD | 1.47% |
| 1997 Q1 | 803.74 Thousand USD | 0.0% |
| 1997 Q3 | 1.51 Million USD | 73.64% |
| 1997 Q4 | 1.47 Million USD | -2.39% |
| 1997 FY | 1.47 Million USD | -66.86% |
| 1997 Q2 | 870.7 Thousand USD | 8.33% |
| 1996 FY | 4.45 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Aurora Cannabis Inc. | 236.8 Million CAD | 58.346% |
| Avicanna Inc. | 13.99 Million CAD | -604.615% |
| Avant Brands Inc. | 33.22 Million CAD | -196.891% |
| Cardiol Therapeutics Inc. | 8.45 Million CAD | -1066.773% |
| Crescita Therapeutics Inc. | 5.77 Million CAD | -1607.739% |
| Knight Therapeutics Inc. | 198.62 Million CAD | 50.338% |
| MediPharm Labs Corp. | 10.93 Million CAD | -802.296% |
| OrganiGram Holdings Inc. | 26.83 Million CAD | -267.617% |
| Canopy Growth Corporation | 799.82 Million CAD | 87.667% |
| Willow Biosciences Inc. | 3.23 Million CAD | -2947.235% |
| Auxly Cannabis Group Inc. | 210.85 Million CAD | 53.22% |